Back to Search

KEVIN PACKMAN, MD

MD

Surgery Physician

NPI: 1437159399IndividualAccepts Medicare

Specialties, Licenses & Credentials

Surgery PhysicianPrimary

Surgery

Code: 208600000X

33416(WI)
Vascular Surgery Physician

Surgery — Vascular Surgery

Code: 2086S0129X

33416(WI)

CMS Specialties

PrimaryGENERAL SURGERY

Education

WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE

Class of 1991

Research & Publications (13)

Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts.
PMID 19331137·Anticancer Res·2009
7-preclinical
Characterization of a novel mitogen-activated protein kinase kinase 1/2 inhibitor with a unique mechanism of action for cancer therapy.
PMID 19244124·Cancer Res·2009
7-preclinical
In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models.
PMID 19139115·Mol Cancer Ther·2009
7-preclinical
Mesenchymal stem cells in early entry of breast cancer into bone marrow.
PMID 18575622·PLoS One·2008
7-preclinical
In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials.
PMID 17121911·Mol Cancer Ther·2006
7-preclinical
Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity.
PMID 17064073·J Med Chem·2006
7-preclinical
Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
PMID 16928815·Mol Cancer Ther·2006
7-preclinical
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.
PMID 16443686·Proc Natl Acad Sci U S A·2006
7-preclinical
Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.
PMID 15746940·Cell Death Differ·2005
8-other
Antiandrogen-induced cell death in LNCaP human prostate cancer cells.
PMID 12815459·Cell Death Differ·2003
8-other
Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.
PMID 12711002·J Steroid Biochem Mol Biol·2003
7-preclinical
Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells.
PMID 12650706·J Steroid Biochem Mol Biol·2002
8-other
Vitamin D(3) receptor ablation alters mammary gland morphogenesis.
PMID 12070083·Development·2002
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
5150 N PORT WASHINGTON RD, SUITE 151
MILWAUKEE, WI 53217

Location

Practice Location

5150 N PORT WASHINGTON RD, MILWAUKEE, WI
(414) 332-1000

Quick Facts

NPI
1437159399
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
35
Publications
13

Are you this provider?

Claim Your Profile